Galluzzi, Lorenzo

Publications

Sort by

Co-Author Network

selected publications

The DNA Damage Response and Inflammation in Cancer. Cancer discovery. 2023 Academic Article GET IT
Cell death and senescence. Journal of translational medicine. 2023 Editorial Article GET IT
Times cited: 311
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6^th annual ImmunoRad conference. Oncoimmunology. 2023 Review GET IT
Times cited: 511
Emerging evidence for adapting radiotherapy to immunotherapy. Nature reviews. Clinical oncology. 2023 Review GET IT
Times cited: 5387
Ca²⁺ signaling and cell death. Cell calcium. 2023 Review GET IT
Calreticulin exposure orchestrates innate immunosurveillance. Cancer cell. 2023 Academic Article GET IT
Immunologically relevant effects of radiation therapy on the tumor microenvironment. Essays in biochemistry. 2023 Academic Article GET IT
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. Cell death & disease. 2023 Academic Article GET IT
Times cited: 2
Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell death and differentiation. 2023 Review GET IT
Epigenetic escape of immunosurveillance by malignant cell precursors. The EMBO journal. 2023 Academic Article GET IT
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients. Cell death & disease. 2023 Academic Article GET IT
p53 regulates the mitochondrial immune checkpoint. Trends in immunology. 2023 Academic Article GET IT
Immunogenic cell death in cancer: concept and therapeutic implications. Journal of translational medicine. 2023 Review GET IT
Times cited: 1
Cellular senescence in the response of HR⁺ breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine. 2023 Academic Article GET IT
Adaptation to MOMP drives cancer persistence. Cell research. 2023 Comment GET IT
Times cited: 1
Meta-hallmarks of aging and cancer. Cell metabolism. 2023 Review GET IT
Times cited: 15
Myeloid-derived suppressor cells: Emerging players in cancer and beyond. International review of cell and molecular biology. 2023 Editorial Article GET IT
Radiation therapy: An old dog learning new tricks. Methods in cell biology. 2023 Academic Article GET IT
T cell-independent abscopal responses to radiotherapy. Trends in cancer. 2022 Academic Article GET IT
NK cells and solid tumors: therapeutic potential and persisting obstacles. Molecular cancer. 2022 Review GET IT
Times cited: 9
Quantitative assessment of mitophagy in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
Calreticulin surface presentation can promote quality control of hematopoietic stem cells. Trends in immunology. 2022 Comment GET IT
Immuno-epigenetic escape of cancer stem cells. Nature immunology. 2022 Comment GET IT
Times cited: 3
PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes. Science immunology. 2022 Academic Article GET IT
Times cited: 8
Mitochondrial control of inflammation. Nature reviews. Immunology. 2022 Review GET IT
Times cited: 54
Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis. Methods in cell biology. 2022 Academic Article GET IT
An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2022 Academic Article GET IT
Times cited: 7
RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
Developing antisense oligonucleotides for a TECPR2 mutation-induced, ultra-rare neurological disorder using patient-derived cellular models. Molecular therapy. Nucleic acids. 2022 Academic Article GET IT
Times cited: 495
Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Methods in cell biology. 2022 Academic Article GET IT
Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer immunology research. 2022 Academic Article GET IT
Times cited: 15
Catastrophic DNA replication in unscheduled tetraploid cells. Trends in genetics : TIG. 2022 Comment GET IT
Times cited: 1
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients. Oncoimmunology. 2022 Academic Article GET IT
Times cited: 2
Restored Ketosis Drives Anticancer Immunity in Colorectal Cancer. Cancer research. 2022 Comment GET IT
Times cited: 1
Author Correction: Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nature reviews. Clinical oncology. 2022 Article GET IT
BAX and BAK dynamics control mitochondrial DNA release during apoptosis. Cell death and differentiation. 2022 Academic Article GET IT
Times cited: 6
Platinum-based chemotherapy inflames the ovarian carcinoma microenvironment through cellular senescence. Oncoimmunology. 2022 Editorial Article GET IT
Times cited: 1
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nature reviews. Drug discovery. 2022 Review GET IT
Times cited: 30
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. Trends in cancer. 2022 Review GET IT
Times cited: 9
Immunogenic cell stress and death. Nature immunology. 2022 Review GET IT
Times cited: 180
Immunostimulatory effects of radioimmunotherapy. Journal for immunotherapy of cancer. 2022 Academic Article GET IT
Times cited: 3
Cytofluorometric assessment of cell cycle progression in irradiated cells. Methods in cell biology. 2022 Academic Article GET IT
Times cited: 1
Emergent impact of lifestyle on tumor progression and response to therapy. International review of cell and molecular biology. 2022 Editorial Article GET IT
Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives. International review of cell and molecular biology. 2022 Editorial Article GET IT
Radiation therapy: An old dog learning new tricks. Methods in cell biology. 2022 Editorial Article GET IT
Using epigenetic modifiers to target cancer stem cell immunoevasion. Cancer cell. 2021 Comment GET IT
Times cited: 6
MDSCs sneak CSCs out of (immuno)surveillance. Trends in immunology. 2021 Academic Article GET IT
Times cited: 3
Multimodal immunostimulation to control BRCA1-defective ovarian carcinoma. Trends in cancer. 2021 Academic Article GET IT
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nature reviews. Clinical oncology. 2021 Review GET IT
Times cited: 43
Trial watch: intratumoral immunotherapy. Oncoimmunology. 2021 Review GET IT
Times cited: 19
Control of host mitochondria by bacterial pathogens. Trends in microbiology. 2021 Review GET IT
Times cited: 12
Immunological configuration of ovarian carcinoma: features and impact on disease outcome. Journal for immunotherapy of cancer. 2021 Review GET IT
Times cited: 20
Autophagy in major human diseases. The EMBO journal. 2021 Review GET IT
Times cited: 318
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology. 2021 Academic Article GET IT
Times cited: 25
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial. Gynecologic oncology. 2021 Academic Article GET IT
Times cited: 9
Targeting Serine in Cancer: Is Two Better Than One?. Trends in cancer. 2021 Academic Article GET IT
Times cited: 6
Immunological barriers to immunotherapy in primary and metastatic breast cancer. EMBO molecular medicine. 2021 Academic Article GET IT
Times cited: 3
ATP and cancer immunosurveillance. The EMBO journal. 2021 Review GET IT
Times cited: 65
Could Protons Promote Tumor Control by Avoiding Lymphopenia?. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2021 Letter GET IT
Times cited: 2
Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells. STAR protocols. 2021 Academic Article GET IT
Times cited: 3
Immunology of Cell Death in Cancer Immunotherapy. Cells. 2021 Editorial Article GET IT
Times cited: 7
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients. Cell reports. 2021 Academic Article GET IT
Times cited: 16
Targeting replication stress to tackle cancer stem cells. Cell death & disease. 2021 Comment GET IT
Times cited: 1
Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery. Immunity. 2021 Academic Article GET IT
Times cited: 14
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients. Oncoimmunology. 2021 Academic Article GET IT
Times cited: 12
Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms. The Journal of clinical investigation. 2021 Review GET IT
Times cited: 51
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. The Journal of clinical investigation. 2021 Academic Article GET IT
Times cited: 75
Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents. Oncoimmunology. 2021 Editorial Article GET IT
Times cited: 14
Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nature medicine. 2021 Review GET IT
Times cited: 228
Oncosuppressive functions of PIDD1 in response to centrosome amplification. Cell death & disease. 2021 Comment GET IT
Exogenous and Endogenous Sources of Serine Contribute to Colon Cancer Metabolism, Growth, and Resistance to 5-Fluorouracil. Cancer research. 2021 Academic Article GET IT
Times cited: 40
Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy. Trends in cancer. 2021 Comment GET IT
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER⁺ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Academic Article GET IT
Times cited: 33
Ketosis versus carbotoxicity - metabolism determines the outcome of cancer immunotherapy. Molecular & cellular oncology. 2021 Academic Article GET IT
Times cited: 80
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. Trends in cancer. 2021 Review GET IT
Times cited: 20
Ca²⁺ in health and disease. International review of cell and molecular biology. 2021 Editorial Article GET IT
Chromatin and genomic instability in cancer. International review of cell and molecular biology. 2021 Editorial Article GET IT
Times cited: 2
Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives. International review of cell and molecular biology. 2021 Editorial Article GET IT
Preface: Ca²⁺ in health and disease. International review of cell and molecular biology. 2021 Editorial Article GET IT
Preface: Chemical carcinogenesis in mice as a model of human cancer: Pros and cons. Methods in cell biology. 2021 Editorial Article GET IT
Vesicular trafficking in cellular responses to stress. Methods in cell biology. 2021 Editorial Article GET IT
Times cited: 1
Vesicular trafficking in cellular responses to stress. Methods in cell biology. 2021 Editorial Article GET IT
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Life science alliance. 2020 Academic Article GET IT
Times cited: 34
Immunomodulation by targeted anticancer agents. Cancer cell. 2020 Review GET IT
Times cited: 90
Autophagy in the cancer-immunity dialogue. Advanced drug delivery reviews. 2020 Review GET IT
Times cited: 35
Detection of immunogenic cell death and its relevance for cancer therapy. Cell death & disease. 2020 Review GET IT
Times cited: 284
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade. Oncoimmunology. 2020 Academic Article GET IT
Times cited: 24
MPA/DMBA-driven mammary carcinomas. Methods in cell biology. 2020 Academic Article GET IT
Times cited: 2
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications. 2020 Academic Article GET IT
Caspase 2 and p53 Reunited in Tumor Control. Trends in cell biology. 2020 Comment GET IT
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression. medRxiv : the preprint server for health sciences. 2020 Article GET IT
NK cells beat T cells at early breast cancer control. Oncoimmunology. 2020 Editorial Article GET IT
Times cited: 9
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature reviews. Clinical oncology. 2020 Review GET IT
Times cited: 457
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature immunology. 2020 Academic Article GET IT
Times cited: 156
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer. Journal for immunotherapy of cancer. 2020 Academic Article GET IT
Times cited: 39
Calreticulin and cancer. Cell research. 2020 Review GET IT
Times cited: 108
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications. 2020 Academic Article GET IT
Times cited: 58
Mitochondrial control of innate immune signaling by irradiated cancer cells. Oncoimmunology. 2020 Editorial Article GET IT
Times cited: 21
Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. Oncoimmunology. 2020 Review GET IT
Times cited: 50
Ca²⁺ Fluxes and Cancer. Molecular cell. 2020 Review GET IT
Times cited: 101
Trial watch: STING agonists in cancer therapy. Oncoimmunology. 2020 Review GET IT
Times cited: 123
Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 2020 Review GET IT
Times cited: 76
Possible mechanisms of cancer prevention by nicotinamide. British journal of pharmacology. 2020 Review GET IT
Times cited: 8
Trial watch: TLR3 agonists in cancer therapy. Oncoimmunology. 2020 Review GET IT
Times cited: 56
Senescence Inflames the Pancreatic Tumor Microenvironment. Cell reports. Medicine. 2020 Comment GET IT
Times cited: 3
Immunomodulation by anticancer cell cycle inhibitors. Nature reviews. Immunology. 2020 Review GET IT
Times cited: 72
Noncanonical Cell Fate Regulation by Bcl-2 Proteins. Trends in cell biology. 2020 Review GET IT
Times cited: 58
Immunogenicity of cell death driven by immune effectors. Journal for immunotherapy of cancer. 2020 Comment GET IT
Times cited: 9
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal for immunotherapy of cancer. 2020 Review GET IT
Times cited: 459
Cancer Immunotherapy with CDK7 Inhibitors. Trends in cancer. 2020 Comment GET IT
Times cited: 1
Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors?. Trends in cell biology. 2020 Academic Article GET IT
Times cited: 4
PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. Oncoimmunology. 2020 Academic Article GET IT
Times cited: 64
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. Oncoimmunology. 2020 Review GET IT
Times cited: 132
Autophagy in hepatic adaptation to stress. Journal of hepatology. 2020 Review GET IT
Times cited: 95
Correction to: Methods to Detect Immunogenic Cell Death In Vivo. Methods in molecular biology (Clifton, N.J.). 2020 Academic Article GET IT
Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment. Cancer treatment and research. 2020 Academic Article GET IT
Times cited: 8
Methods to Detect Immunogenic Cell Death In Vivo. Methods in molecular biology (Clifton, N.J.). 2020 Academic Article GET IT
Times cited: 5
Preface - Extracellular vesicles: An exciting and rapidly expanding field of investigation. Methods in enzymology. 2020 Editorial Article GET IT
Preface-Autophagy: An old mechanism with new challenges ahead. Progress in molecular biology and translational science. 2020 Editorial Article GET IT
Times cited: 3
Preface: Endoplasmic reticulum in health and disease. International review of cell and molecular biology. 2020 Editorial Article GET IT
Times cited: 4
Preface: Life through death-Key role of cellular suicide for colonial and organismal homeostasis. International review of cell and molecular biology. 2020 Editorial Article GET IT
Preface: Life through death-Key role of cellular suicide for colonial and organismal homeostasis. International review of cell and molecular biology. 2020 Editorial Article GET IT
Times cited: 1
Preface: Life through death-Key role of cellular suicide for colonial and organismal homeostasis. International review of cell and molecular biology. 2020 Editorial Article GET IT
Preface: More than two decades of modern tumor immunology. Methods in enzymology. 2020 Editorial Article GET IT
Times cited: 1
Preface: More than two decades of modern tumor immunology. Methods in enzymology. 2020 Editorial Article GET IT
Preface: More than two decades of modern tumor immunology. Methods in enzymology. 2020 Editorial Article GET IT
Preface: More than two decades of modern tumor immunology. Methods in enzymology. 2020 Editorial Article GET IT
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nature immunology. 2019 Review GET IT
Times cited: 166
Targeting Mutant KRAS for Immunogenic Cell Death Induction. Trends in pharmacological sciences. 2019 Comment GET IT
Times cited: 2
Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell metabolism. 2019 Article GET IT
Times cited: 7
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal for immunotherapy of cancer. 2019 Academic Article GET IT
Times cited: 44
Calreticulin arms NK cells against leukemia. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 13
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients. Haematologica. 2019 Academic Article GET IT
Times cited: 26
Today's Special on the Anticancer Menu: Immunomodulation by Antifolates. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Comment GET IT
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles. Nature reviews. Drug discovery. 2019 Review GET IT
Times cited: 98
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 83
Apoptotic caspases cut down the immunogenicity of radiation. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 20
Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell metabolism. 2019 Academic Article GET IT
Times cited: 57
Extracorporeal photochemotherapy induces bona fide immunogenic cell death. Cell death & disease. 2019 Academic Article GET IT
Times cited: 40
Drugging cancer metabolism: Expectations vs. reality. International review of cell and molecular biology. 2019 Review GET IT
Times cited: 18
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. The Lancet. Oncology. 2019 Review GET IT
Times cited: 114
Trial watch: dendritic cell vaccination for cancer immunotherapy. Oncoimmunology. 2019 Review GET IT
Times cited: 93
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Journal for immunotherapy of cancer. 2019 Article GET IT
Times cited: 2
Macrophages and Metabolism in the Tumor Microenvironment. Cell metabolism. 2019 Review GET IT
Times cited: 664
Autophagy-Independent Functions of the Autophagy Machinery. Cell. 2019 Review GET IT
Times cited: 460
Heterogeneous cellular effects of α-ketoglutarate esters. Aging. 2019 Editorial Article GET IT
Times cited: 2
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Journal for immunotherapy of cancer. 2019 Review GET IT
Times cited: 49
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 52
Radiation unlocks the therapeutic potential of immune checkpoint blockers in lung cancer patients. Oncoimmunology. 2019 Editorial Article GET IT
Times cited: 1
Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate. Cell reports. 2019 Academic Article GET IT
Times cited: 28
Stress responses in stromal cells and tumor homeostasis. Pharmacology & therapeutics. 2019 Review GET IT
Times cited: 21
Monitoring abscopal responses to radiation in mice. Methods in enzymology. 2019 Academic Article GET IT
Times cited: 2
Cancer Cells Thrive on Stress. Trends in cell biology. 2019 Review GET IT
Trial watch: dietary interventions for cancer therapy. Oncoimmunology. 2019 Review GET IT
Times cited: 36
Metabolic enzymes expressed by cancer cells impact the immune infiltrate. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 12
Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. Trends in cell biology. 2019 Review GET IT
Times cited: 56
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. Journal for immunotherapy of cancer. 2019 Academic Article GET IT
Times cited: 49
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. Journal for immunotherapy of cancer. 2019 Academic Article GET IT
Times cited: 59
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing. BMC medical informatics and decision making. 2019 Academic Article GET IT
Times cited: 8
Born to Kill: NK Cells Go to War against Cancer. Trends in cancer. 2019 Letter GET IT
Times cited: 2
Nucleic Acid Sensing at the Interface Between Innate and Adaptive Immunity. International review of cell and molecular biology. 2019 Editorial Article GET IT
Times cited: 2
Nucleic Acid Sensing at the Interface Between Innate and Adaptive Immunity. International review of cell and molecular biology. 2019 Editorial Article GET IT
Times cited: 1
Preface-Dendritic cells: Master regulators of innate and adaptive immunity. International review of cell and molecular biology. 2019 Editorial Article GET IT
Times cited: 1
Preface: Dendritic cells: Master regulators of innate and adaptive immunity. International review of cell and molecular biology. 2019 Editorial Article GET IT
Times cited: 1
Preface: More than two decades of modern tumor immunology. Methods in enzymology. 2019 Editorial Article GET IT
T Cells: Friends and Foes. International review of cell and molecular biology. 2019 Article GET IT
Times cited: 2
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nature reviews. Cardiology. 2019 Review GET IT
Times cited: 145
Etiological involvement of CFTR in apparently unrelated human diseases. Molecular & cellular oncology. 2018 Academic Article GET IT
Times cited: 22
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. Journal for immunotherapy of cancer. 2018 Academic Article GET IT
Times cited: 95
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca²⁺ levels and tumor growth. The EMBO journal. 2018 Academic Article GET IT
Times cited: 63
Linking cellular stress responses to systemic homeostasis. Nature reviews. Molecular cell biology. 2018 Review GET IT
Times cited: 242
Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate. Oncoimmunology. 2018 Editorial Article GET IT
Times cited: 12
Trial Watch: Toll-like receptor agonists in cancer immunotherapy. Oncoimmunology. 2018 Review GET IT
Times cited: 145
T Cells: Friends and Foes. International review of cell and molecular biology. 2018 Academic Article GET IT
Times cited: 1
The hallmarks of successful anticancer immunotherapy. Science translational medicine. 2018 Review GET IT
Times cited: 348
WNT Signaling in Cancer Immunosurveillance. Trends in cell biology. 2018 Review GET IT
Times cited: 130
Trial watch: Peptide-based vaccines in anticancer therapy. Oncoimmunology. 2018 Review GET IT
Times cited: 108
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. Oncoimmunology. 2018 Review GET IT
Times cited: 61
Modeling Tumor Immunology and Immunotherapy in Mice. Trends in cancer. 2018 Academic Article GET IT
Times cited: 51
Cytosolic DNA Sensing in Organismal Tumor Control. Cancer cell. 2018 Review GET IT
Times cited: 149
PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab. Oncoimmunology. 2018 Academic Article GET IT
Times cited: 15
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden. Journal for immunotherapy of cancer. 2018 Academic Article GET IT
Times cited: 94
Oncogene-induced senescence and tumour control in complex biological systems. Cell death and differentiation. 2018 Editorial Article GET IT
Times cited: 51
SnapShot: CGAS-STING Signaling. Cell. 2018 Review GET IT
Times cited: 97
BAX and BAK at the Gates of Innate Immunity. Trends in cell biology. 2018 Comment GET IT
Times cited: 13
The autophagic network and cancer. Nature cell biology. 2018 Review GET IT
Times cited: 206
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology. 2018 Review GET IT
Times cited: 30
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell death and differentiation. 2018 Review GET IT
Times cited: 2998
Guidelines and recommendations on yeast cell death nomenclature. Microbial cell (Graz, Austria). 2018 Review GET IT
Times cited: 89
Everybody In! No Bouncers at Tumor Gates. Trends in genetics : TIG. 2017 Comment GET IT
Times cited: 2
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers. Seminars in cancer biology. 2017 Review GET IT
Times cited: 44
Mitochondrial metabolism and cancer. Cell research. 2017 Review GET IT
Times cited: 633
Fighting Resilient Cancers with Iron. Trends in cell biology. 2017 Review GET IT
Times cited: 37
Trial watch: DNA-based vaccines for oncological indications. Oncoimmunology. 2017 Review GET IT
Times cited: 23
Immune recognition of irradiated cancer cells. Immunological reviews. 2017 Review GET IT
Times cited: 61
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors. The Journal of molecular diagnostics : JMD. 2017 Academic Article GET IT
Times cited: 39
CARs on a highway with roadblocks. Oncoimmunology. 2017 Editorial Article GET IT
Times cited: 6
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology. 2017 Review GET IT
Times cited: 173
Lysosome-targeting agents in cancer therapy. Oncotarget. 2017 Academic Article GET IT
Times cited: 13
The spectrum of T cell metabolism in health and disease. Nature reviews. Immunology. 2017 Review GET IT
Times cited: 236
Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 2017 Review GET IT
Times cited: 56
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. Oncoimmunology. 2017 Review GET IT
Times cited: 32
Control of Metastasis by NK Cells. Cancer cell. 2017 Review GET IT
Times cited: 428
Trial Watch: Adoptively transferred cells for anticancer immunotherapy. Oncoimmunology. 2017 Review GET IT
Times cited: 54
Blinatumomab bridges the gap between leukemia and immunity. Oncoimmunology. 2017 Editorial Article GET IT
Times cited: 4
CD103⁺ cells at the forefront of anticancer immunity. Oncoimmunology. 2017 Editorial Article GET IT
Times cited: 3
Autophagy in natural and therapy-driven anticancer immunosurveillance. Autophagy. 2017 Academic Article GET IT
Times cited: 50
Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade. Oncoimmunology. 2017 Editorial Article GET IT
Times cited: 20
Driving to Cancer on a Four-Lane Expressway. Trends in genetics : TIG. 2017 Academic Article GET IT
Times cited: 5
PD-L1 blockade for urothelial carcinoma. Oncoimmunology. 2017 Editorial Article GET IT
Times cited: 5
TREX1 Cuts Down on Cancer Immunogenicity. Trends in cell biology. 2017 Article GET IT
Times cited: 16
Heavy Metal to Rock the Immune Infiltrate. Trends in immunology. 2017 Comment GET IT
Times cited: 7
Molecular definitions of autophagy and related processes. The EMBO journal. 2017 Review GET IT
Times cited: 1014
Mitochondrial permeability transition involves dissociation of F₁F_O ATP synthase dimers and C-ring conformation. EMBO reports. 2017 Academic Article GET IT
Times cited: 139
Autophagy and Mitophagy in Cardiovascular Disease. Circulation research. 2017 Review GET IT
Times cited: 432
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nature reviews. Drug discovery. 2017 Review GET IT
Times cited: 544
Trial watch: Dendritic cell-based anticancer immunotherapy. Oncoimmunology. 2017 Review GET IT
Times cited: 83
Reply: Immunosuppressive cell death in cancer. Nature reviews. Immunology. 2017 Comment GET IT
Times cited: 12
DNA Damage in Stem Cells. Molecular cell. 2017 Review GET IT
Times cited: 191
Novel immune checkpoint blocker to treat Merkel cell carcinoma. Oncoimmunology. 2017 Academic Article GET IT
Times cited: 1
An epigenetic modifier triggers therapeutic immune responses against breast cancer. Oncoimmunology. 2017 Editorial Article GET IT
Times cited: 2
[Autophagy, fitness and longevity]. Medecine sciences : M/S. 2017 Review GET IT
Times cited: 3
Calreticulin and type I interferon: An unsuspected connection. Oncoimmunology. 2017 Editorial Article GET IT
Times cited: 9
Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors. Oncotarget. 2017 Academic Article GET IT
Times cited: 12
Mitophagy: Permitted by Prohibitin. Current biology : CB. 2017 Comment GET IT
Times cited: 5
Involvement of autophagy in NK cell development and function. Autophagy. 2017 Academic Article GET IT
Times cited: 23
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing. Oncotarget. 2017 Academic Article GET IT
Times cited: 34
Secondary Necrosis: Accidental No More. Trends in cancer. 2017 Comment GET IT
Times cited: 23
Preface. Methods in enzymology. 2017 Editorial Article GET IT
Preface. Methods in enzymology. 2017 Editorial Article GET IT
Times cited: 1
High-Throughput Quantification of GFP-LC3⁺ Dots by Automated Fluorescence Microscopy. Methods in enzymology. 2016 Academic Article GET IT
Times cited: 18
Reply: The complement system is also important in immunogenic cell death. Nature reviews. Immunology. 2016 Letter GET IT
Times cited: 5
Necroptosis: Mechanisms and Relevance to Disease. Annual review of pathology. 2016 Review GET IT
Times cited: 361
Assessment of Glycolytic Flux and Mitochondrial Respiration in the Course of Autophagic Responses. Methods in enzymology. 2016 Academic Article GET IT
Times cited: 6
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nature reviews. Clinical oncology. 2016 Review GET IT
Times cited: 229
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood. 2016 Academic Article GET IT
Times cited: 89
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy. Cancer immunology research. 2016 Review GET IT
Times cited: 117
Immunogenic cell death in cancer and infectious disease. Nature reviews. Immunology. 2016 Review GET IT
Times cited: 1618
Immunosuppressive γδ T cells foster pancreatic carcinogenesis. Oncoimmunology. 2016 Editorial Article GET IT
Times cited: 1742
Aberrant ketolysis fuels hepatocellular cancer progression. Cell research. 2016 Comment GET IT
Times cited: 4
Novel Insights into PML-Dependent Oncosuppression. Trends in cell biology. 2016 Comment GET IT
Times cited: 5
Metabolic Control of Longevity. Cell. 2016 Review GET IT
Times cited: 477
Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 2016 Review GET IT
Times cited: 653
Prevention of breast cancer by RANKL/RANK blockade. Cell research. 2016 Comment GET IT
Times cited: 4
Autophagy in acute brain injury. Nature reviews. Neuroscience. 2016 Review GET IT
Times cited: 151
A four-lane highway to cancer. Nature reviews. Molecular cell biology. 2016 Comment GET IT
Times cited: 3
Amino acid deprivation promotes intestinal homeostasis through autophagy. Oncotarget. 2016 Editorial Article GET IT
Times cited: 2
Defective Autophagy Initiates Malignant Transformation. Molecular cell. 2016 Comment GET IT
Times cited: 21
Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties. Trends in cell biology. 2016 Review GET IT
Times cited: 159
Regulated cell death and adaptive stress responses. Cellular and molecular life sciences : CMLS. 2016 Review GET IT
Times cited: 99
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 2016 Review GET IT
Times cited: 40
Mitochondrial regulation of cell death: a phylogenetically conserved control. Microbial cell (Graz, Austria). 2016 Review GET IT
Times cited: 191
Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity. 2016 Review GET IT
Times cited: 245
STAT3 inhibition for cancer therapy: Cell-autonomous effects only?. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 75
Cytofluorometric Quantification of Cell Death Elicited by NLR Proteins. Methods in molecular biology (Clifton, N.J.). 2016 Academic Article GET IT
Times cited: 1
Detection of Apoptotic Versus Autophagic Cell Death by Flow Cytometry. Methods in molecular biology (Clifton, N.J.). 2016 Academic Article GET IT
Times cited: 2
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer cell. 2015 Review GET IT
Times cited: 1017
First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 981
Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 2015 Review GET IT
Times cited: 155
Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 2015 Review GET IT
Times cited: 18
Defective autophagy gets to the brain. Oncotarget. 2015 Editorial Article GET IT
Times cited: 2
Autophagy Mediates Tumor Suppression via Cellular Senescence. Trends in cell biology. 2015 Comment GET IT
Times cited: 31
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in immunology. 2015 Academic Article GET IT
Times cited: 153
Molecular Regulation of Circadian Rhythms by Polyamines. Cell metabolism. 2015 Comment GET IT
Times cited: 4
Doubling the blockade for melanoma immunotherapy. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 59
Karyotypic Aberrations in Oncogenesis and Cancer Therapy. Trends in cancer. 2015 Review GET IT
Times cited: 26
Natural and therapy-induced immunosurveillance in breast cancer. Nature medicine. 2015 Review GET IT
Times cited: 226
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 2015 Review GET IT
Times cited: 122
Organelle-Specific Initiation of Autophagy. Molecular cell. 2015 Review GET IT
Times cited: 156
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in immunology. 2015 Review GET IT
Times cited: 300
Ferroptosis in p53-dependent oncosuppression and organismal homeostasis. Cell death and differentiation. 2015 Editorial Article GET IT
Times cited: 30
Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo. Cell cycle (Georgetown, Tex.). 2015 Academic Article GET IT
Times cited: 28
Necrosis: Linking the Inflammasome to Inflammation. Cell reports. 2015 Comment GET IT
Times cited: 7
Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?. Oncoimmunology. 2015 Editorial Article GET IT
Times cited: 435
Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-An exclamation sign with a question mark. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 92
Acetyl coenzyme A: a central metabolite and second messenger. Cell metabolism. 2015 Review GET IT
Times cited: 761
Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death". Frontiers in immunology. 2015 Article GET IT
Times cited: 9
Type I interferons in anticancer immunity. Nature reviews. Immunology. 2015 Review GET IT
Times cited: 749
Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 2015 Review GET IT
Times cited: 93
Combinatorial strategies for the induction of immunogenic cell death. Frontiers in immunology. 2015 Review GET IT
Times cited: 220
Quantification of cellular viability by automated microscopy and flow cytometry. Oncotarget. 2015 Academic Article GET IT
Times cited: 13
Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 2015 Academic Article GET IT
Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 2015 Article GET IT
Times cited: 51
Novel function of cytoplasmic p53 at the interface between mitochondria and the endoplasmic reticulum. Cell death & disease. 2015 Academic Article GET IT
Times cited: 10
eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in cancer biology. 2015 Review GET IT
Times cited: 84
Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 460
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology. 2015 Review GET IT
Times cited: 1456
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 2015 Review GET IT
Times cited: 11
Autophagy in malignant transformation and cancer progression. The EMBO journal. 2015 Review GET IT
Times cited: 911
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 2015 Review GET IT
Times cited: 717
Cancer and the gut microbiota: an unexpected link. Science translational medicine. 2015 Review GET IT
Times cited: 320
Unsaturated fatty acids induce non-canonical autophagy. The EMBO journal. 2015 Academic Article GET IT
Times cited: 138
Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 2015 Review GET IT
Times cited: 5
Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy. 2015 Academic Article GET IT
Times cited: 16
Classification of current anticancer immunotherapies. Oncotarget. 2014 Review GET IT
Times cited: 340
Novel immune checkpoint blocker approved for the treatment of advanced melanoma. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 115
Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 2014 Review GET IT
Times cited: 48
Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 2014 Review GET IT
Times cited: 95
Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014 Review GET IT
Times cited: 264
Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology. 2014 Review GET IT
Times cited: 100
Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 658
Metabolic control of autophagy. Cell. 2014 Review GET IT
Times cited: 634
Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & cellular oncology. 2014 Review GET IT
Times cited: 5
Molecular and Cellular Oncology: A new journal for a changing field. Molecular & cellular oncology. 2014 Academic Article GET IT
Cell biology. Metabolic control of cell death. Science (New York, N.Y.). 2014 Review GET IT
Times cited: 488
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell death and differentiation. 2014 Review GET IT
Times cited: 696
Organelle-specific initiation of cell death. Nature cell biology. 2014 Review GET IT
Times cited: 183
Trial Watch: Toll-like receptor agonists in oncological indications. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 158
Chloroquine and hydroxychloroquine for cancer therapy. Molecular & cellular oncology. 2014 Review GET IT
Times cited: 162
Impact of myeloid cells on the efficacy of anticancer chemotherapy. Current opinion in immunology. 2014 Review GET IT
Times cited: 33
Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology. 2014 Academic Article GET IT
Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 2014 Review GET IT
Times cited: 23
Systems biology of cisplatin resistance: past, present and future. Cell death & disease. 2014 Review GET IT
Times cited: 558
Molecular and Cellular Oncology: A new journal for a changing field. Molecular & cellular oncology. 2014 Academic Article GET IT
Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 2014 Review GET IT
Times cited: 366
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 81
Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 2014 Review GET IT
Times cited: 236
Trial Watch: DNA vaccines for cancer therapy. Oncoimmunology. 2014 Review GET IT
Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 2014 Review GET IT
Times cited: 219
Molecular mechanisms of regulated necrosis. Seminars in cell & developmental biology. 2014 Review GET IT
Times cited: 197
Novel insights into the mechanism of action of lenalidomide. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 542
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 1239
MLKL regulates necrotic plasma membrane permeabilization. Cell research. 2014 Academic Article GET IT
Times cited: 60
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 84
Metabolomic profiling of cultured cancer cells. Methods in enzymology. 2014 Academic Article GET IT
Novel insights into the mitochondrial permeability transition. Cell cycle (Georgetown, Tex.). 2014 Academic Article GET IT
Times cited: 18
Preface: oncometabolism: a new field of research with profound therapeutic implications. Methods in enzymology. 2014 Editorial Article GET IT
Times cited: 3
Preface: oncometabolism: a new field of research with profound therapeutic implications. Methods in enzymology. 2014 Editorial Article GET IT
Times cited: 1
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy. Oncoimmunology. 2014 Review GET IT
Times cited: 91
CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. Cancer research. 2013 Academic Article GET IT
Times cited: 100
Immunological effects of chemotherapy in spontaneous breast cancers. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 182
Immune effectors required for the therapeutic activity of vorinostat. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 256
Trial Watch: Peptide vaccines in cancer therapy. Oncoimmunology. 2013 Review GET IT
Times cited: 78
Trial Watch: Lenalidomide-based immunochemotherapy. Oncoimmunology. 2013 Review GET IT
Times cited: 14
Metabolic targets for cancer therapy. Nature reviews. Drug discovery. 2013 Review GET IT
Times cited: 536
Immunogenic cell death in radiation therapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 156
Common and divergent functions of Beclin 1 and Beclin 2. Cell research. 2013 Comment GET IT
Times cited: 7
Autophagy and cellular immune responses. Immunity. 2013 Review GET IT
Times cited: 326
Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy. 2013 Review GET IT
Times cited: 90
EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell cycle (Georgetown, Tex.). 2013 Academic Article GET IT
Times cited: 39
Characterization of novel MPS1 inhibitors with preclinical anticancer activity. Cell death and differentiation. 2013 Academic Article GET IT
Times cited: 77
New immunotherapeutic paradigms for castration-resistant prostate cancer. Oncoimmunology. 2013 Editorial Article GET IT
Times cited: 11
Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology. 2013 Review GET IT
Times cited: 188
Immunosurveillance as a regulator of tissue homeostasis. Trends in immunology. 2013 Academic Article GET IT
Times cited: 46
Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity. 2013 Review GET IT
Times cited: 658
Antiapoptotic activity of argon and xenon. Cell cycle (Georgetown, Tex.). 2013 Academic Article GET IT
Times cited: 30
Molecular mechanisms of ATP secretion during immunogenic cell death. Cell death and differentiation. 2013 Academic Article GET IT
Times cited: 328
Trial Watch: Anticancer radioimmunotherapy. Oncoimmunology. 2013 Review GET IT
Times cited: 184
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. Cell death and differentiation. 2013 Academic Article GET IT
Times cited: 71
Crosstalk between ER stress and immunogenic cell death. Cytokine & growth factor reviews. 2013 Review GET IT
Times cited: 135
Current trends of anticancer immunochemotherapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 75
Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2013 Review GET IT
Times cited: 74
Regulation of autophagy by stress-responsive transcription factors. Seminars in cancer biology. 2013 Review GET IT
Times cited: 205
Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 2013 Review GET IT
Times cited: 13
Immunological control of cell cycle aberrations for the avoidance of oncogenesis: the case of tetraploidy. Annals of the New York Academy of Sciences. 2013 Academic Article GET IT
Times cited: 6
Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 1057
Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 202
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 480
Trial watch: Oncolytic viruses for cancer therapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 288
Decoding cell death signals in liver inflammation. Journal of hepatology. 2013 Review GET IT
Times cited: 634
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 2013 Academic Article GET IT
Times cited: 492
Cancer immunotherapy turns viral. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 181
Cisplatin resistance associated with PARP hyperactivation. Cancer research. 2013 Academic Article GET IT
Times cited: 138
Trial watch: DNA vaccines for cancer therapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 1793
Novel multifunctional antibody approved for the treatment of breast cancer. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 179
Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 4
Functions of BCL-X L at the Interface between Cell Death and Metabolism. International journal of cell biology. 2013 Academic Article GET IT
Times cited: 69
Rejuvenated T cells attack old tumors. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 40
Trial watch: Cardiac glycosides and cancer therapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 2209
Prognostic value of LIPC in non-small cell lung carcinoma. Cell cycle (Georgetown, Tex.). 2013 Academic Article GET IT
Times cited: 470
Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell cycle (Georgetown, Tex.). 2013 Academic Article GET IT
Times cited: 34
Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses. Oncogene. 2013 Review GET IT
Times cited: 93
Immunosurveillance against tetraploidization-induced colon tumorigenesis. Cell cycle (Georgetown, Tex.). 2013 Academic Article GET IT
Times cited: 40
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 189
Cytofluorometric assessment of cell cycle progression. Methods in molecular biology (Clifton, N.J.). 2013 Academic Article GET IT
Times cited: 8
Fluorescent biosensors for the detection of HMGB1 release. Methods in molecular biology (Clifton, N.J.). 2013 Academic Article GET IT
Times cited: 9
Quantification of cell cycle-arresting proteins. Methods in molecular biology (Clifton, N.J.). 2013 Academic Article GET IT
Trial watch: Monoclonal antibodies in cancer therapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 21
Victories and deceptions in tumor immunology: Stimuvax^®. Oncoimmunology. 2013 Academic Article GET IT
Transgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterations. Cell cycle (Georgetown, Tex.). 2012 Academic Article GET IT
Times cited: 26
Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy. Autophagy. 2012 Academic Article GET IT
Times cited: 47
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 424
Mitochondria: master regulators of danger signalling. Nature reviews. Molecular cell biology. 2012 Review GET IT
Times cited: 531
Trial watch: Peptide vaccines in cancer therapy. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 167
Immunogenic cell death in cancer therapy. Annual review of immunology. 2012 Review GET IT
Times cited: 2087
Immunosurveillance against cancer-associated hyperploidy. Oncotarget. 2012 Editorial Article GET IT
Times cited: 10
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 148
Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer microenvironment : official journal of the International Cancer Microenvironment Society. 2012 Academic Article GET IT
Times cited: 318
Erlotinib antagonizes ABC transporters in acute myeloid leukemia. Cell cycle (Georgetown, Tex.). 2012 Academic Article GET IT
Times cited: 50
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. Oncogene. 2012 Academic Article GET IT
Times cited: 40
Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Molecular cell. 2012 Academic Article GET IT
Times cited: 220
Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell cycle (Georgetown, Tex.). 2012 Academic Article GET IT
Times cited: 85
Mitochondrial control of cellular life, stress, and death. Circulation research. 2012 Review GET IT
Times cited: 368
Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology. 2012 Academic Article GET IT
An immunosurveillance mechanism controls cancer cell ploidy. Science (New York, N.Y.). 2012 Academic Article GET IT
Times cited: 315
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 132
Independent transcriptional reprogramming and apoptosis induction by cisplatin. Cell cycle (Georgetown, Tex.). 2012 Academic Article GET IT
Times cited: 26
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 254
Prognostic impact of vitamin B6 metabolism in lung cancer. Cell reports. 2012 Academic Article GET IT
Times cited: 83
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Science translational medicine. 2012 Academic Article GET IT
Times cited: 312
Mobile effector proteins on phage genomes. Bacteriophage. 2012 Academic Article GET IT
Times cited: 229
Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 42
Preferential killing of p53-deficient cancer cells by reversine. Cell cycle (Georgetown, Tex.). 2012 Academic Article GET IT
Times cited: 33
Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy. 2012 Academic Article GET IT
Times cited: 65
Autophagy mediates the metabolic benefits of endurance training. Circulation research. 2012 Academic Article GET IT
Times cited: 6
Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 320
Trial Watch: Adoptive cell transfer immunotherapy. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 129
Non-apoptotic functions of apoptosis-regulatory proteins. EMBO reports. 2012 Review GET IT
Times cited: 92
3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors. Human gene therapy methods. 2012 Academic Article GET IT
Times cited: 6
Selective killing of p53-deficient cancer cells by SP600125. EMBO molecular medicine. 2012 Academic Article GET IT
Times cited: 44
Inflammasomes in carcinogenesis and anticancer immune responses. Nature immunology. 2012 Review GET IT
Times cited: 367
Reverse Warburg: straight to cancer. Cell cycle (Georgetown, Tex.). 2012 Comment GET IT
Times cited: 15
Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 748
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy. 2012 Academic Article GET IT
Times cited: 77
The secret ally: immunostimulation by anticancer drugs. Nature reviews. Drug discovery. 2012 Review GET IT
Times cited: 552
Direct molecular interactions between Beclin 1 and the canonical NFκB activation pathway. Autophagy. 2012 Academic Article GET IT
Times cited: 29
Vitamin B6 metabolism influences the intracellular accumulation of cisplatin. Cell cycle (Georgetown, Tex.). 2012 Academic Article GET IT
Times cited: 234
Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. The EMBO journal. 2012 Comment GET IT
Times cited: 99
Autophagy is required for the activation of NFκB. Cell cycle (Georgetown, Tex.). 2012 Academic Article GET IT
Times cited: 92
Evaluation of rapamycin-induced cell death. Methods in molecular biology (Clifton, N.J.). 2012 Academic Article GET IT
Times cited: 12
Trial Watch: Monoclonal antibodies in cancer therapy. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 94
Necroptosis turns TNF lethal. Immunity. 2011 Comment GET IT
Times cited: 11
Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (New York, N.Y.). 2011 Academic Article GET IT
Times cited: 1004
Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene. 2011 Academic Article GET IT
Times cited: 51
Inhibition of autophagy by TAB2 and TAB3. The EMBO journal. 2011 Academic Article GET IT
Times cited: 83
Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy. Oncogene. 2011 Review GET IT
Times cited: 60
Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia. Cell cycle (Georgetown, Tex.). 2011 Academic Article GET IT
Times cited: 32
FADD: an endogenous inhibitor of RIP3-driven regulated necrosis. Cell research. 2011 Review GET IT
Times cited: 9
Molecular mechanisms of cisplatin resistance. Oncogene. 2011 Review GET IT
Times cited: 1842
Hormesis, cell death and aging. Aging. 2011 Review GET IT
Times cited: 105
Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (New York, N.Y.). 2011 Review GET IT
Times cited: 877
p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200. Cell cycle (Georgetown, Tex.). 2011 Academic Article GET IT
Times cited: 118
Autophagy and innate immunity ally against bacterial invasion. The EMBO journal. 2011 Academic Article GET IT
Times cited: 26
Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia. Cell cycle (Georgetown, Tex.). 2011 Academic Article GET IT
Times cited: 38
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell death and differentiation. 2011 Review GET IT
Times cited: 1946
Mitochondrial dynamics: a strategy for avoiding autophagy. Current biology : CB. 2011 Academic Article GET IT
Times cited: 13
A yeast BH3-only protein mediates the mitochondrial pathway of apoptosis. The EMBO journal. 2011 Academic Article GET IT
Times cited: 110
Viperin turns coat in cytomegalovirus infection. Developmental cell. 2011 Comment GET IT
Times cited: 1
Longevity-relevant regulation of autophagy at the level of the acetylproteome. Autophagy. 2011 Academic Article GET IT
Times cited: 33
Cell death signaling and anticancer therapy. Frontiers in oncology. 2011 Academic Article GET IT
Times cited: 532
Mitotic catastrophe: a mechanism for avoiding genomic instability. Nature reviews. Molecular cell biology. 2011 Review GET IT
Times cited: 604
Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. The Journal of clinical investigation. 2011 Academic Article GET IT
Times cited: 136
The grand challenges to cellular and molecular oncology. Frontiers in oncology. 2011 Academic Article GET IT
Past, present, and future of molecular and cellular oncology. Frontiers in oncology. 2011 Academic Article GET IT
Times cited: 439
Cell death assays for drug discovery. Nature reviews. Drug discovery. 2011 Review GET IT
Times cited: 437
Mitochondrial control of the NLRP3 inflammasome. Nature immunology. 2011 Comment GET IT
Times cited: 132
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer metastasis reviews. 2011 Review GET IT
Times cited: 223
Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. The Journal of cell biology. 2011 Academic Article GET IT
Times cited: 381
Mitochondrial liaisons of p53. Antioxidants & redox signaling. 2011 Review GET IT
Times cited: 61
Cytofluorometric purification of diploid and tetraploid cancer cells. Methods in molecular biology (Clifton, N.J.). 2011 Academic Article GET IT
Times cited: 6
Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. Cancer journal (Sudbury, Mass.). 2011 Review GET IT
Times cited: 71
Programmed necrosis from molecules to health and disease. International review of cell and molecular biology. 2011 Review GET IT
Times cited: 127
Oncosuppressive functions of autophagy. Antioxidants & redox signaling. 2010 Review GET IT
Times cited: 80
Illicit survival of cancer cells during polyploidization and depolyploidization. Cell death and differentiation. 2010 Review GET IT
Times cited: 110
Surface-exposed calreticulin in the interaction between dying cells and phagocytes. Annals of the New York Academy of Sciences. 2010 Review GET IT
Times cited: 81
Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature reviews. Molecular cell biology. 2010 Review GET IT
Times cited: 1753
TP53 and MTOR crosstalk to regulate cellular senescence. Aging. 2010 Editorial Article GET IT
Times cited: 76
Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cells. Cell cycle (Georgetown, Tex.). 2010 Academic Article GET IT
Times cited: 11
A new role for cytoplasmic p53: binding and destroying double-stranded RNA. Cell cycle (Georgetown, Tex.). 2010 Comment GET IT
Times cited: 8
Targeting mitochondria for cancer therapy. Nature reviews. Drug discovery. 2010 Review GET IT
Times cited: 1310
Viral strategies for the evasion of immunogenic cell death. Journal of internal medicine. 2010 Review GET IT
Times cited: 52
Pyroptosis - a cell death modality of its kind?. European journal of immunology. 2010 Review GET IT
Times cited: 112
Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. The EMBO journal. 2010 Academic Article GET IT
Times cited: 121
Bacterial invasion: linking autophagy and innate immunity. Current biology : CB. 2010 Academic Article GET IT
Times cited: 13
miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer research. 2010 Academic Article GET IT
Times cited: 254
Autophagy regulation by p53. Current opinion in cell biology. 2010 Review GET IT
Times cited: 415
Defective autophagy control by the p53 rheostat in cancer. Cell cycle (Georgetown, Tex.). 2010 Review GET IT
Times cited: 37
The life span-prolonging effect of sirtuin-1 is mediated by autophagy. Autophagy. 2010 Review GET IT
Times cited: 123
An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe. Cell death & disease. 2010 Academic Article GET IT
Times cited: 34
Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell death & disease. 2010 Academic Article GET IT
Times cited: 476
IKK connects autophagy to major stress pathways. Autophagy. 2010 Review GET IT
Times cited: 38
Disruption of the PP1/GADD34 complex induces calreticulin exposure. Cell cycle (Georgetown, Tex.). 2009 Academic Article GET IT
Times cited: 34
Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol. Aging. 2009 Review GET IT
Times cited: 170
The IKK complex contributes to the induction of autophagy. The EMBO journal. 2009 Academic Article GET IT
Times cited: 240
Targeting HSP70 for cancer therapy. Molecular cell. 2009 Academic Article GET IT
Times cited: 44
Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery. Cell death and differentiation. 2009 Review GET IT
Times cited: 89
Mitochondrial gateways to cancer. Molecular aspects of medicine. 2009 Review GET IT
Times cited: 222
RIP kinases initiate programmed necrosis. Journal of molecular cell biology. 2009 Academic Article GET IT
Times cited: 99
Mitochondrial membrane permeabilization in neuronal injury. Nature reviews. Neuroscience. 2009 Review GET IT
Times cited: 336
Nutlin kills cancer cells via mitochondrial p53. Cell cycle (Georgetown, Tex.). 2009 Comment GET IT
Times cited: 7
p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis. Cell cycle (Georgetown, Tex.). 2009 Academic Article GET IT
Times cited: 32
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene. 2009 Academic Article GET IT
Times cited: 48
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell death and differentiation. 2009 Review GET IT
Times cited: 555
The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell death and differentiation. 2009 Academic Article GET IT
Times cited: 246
Viral subversion of immunogenic cell death. Cell cycle (Georgetown, Tex.). 2009 Review GET IT
Times cited: 54
Shigella targets the mitochondrial checkpoint of programmed necrosis. Cell host & microbe. 2009 Comment GET IT
Times cited: 21
NF-kappaB blockade upregulates Bax, TSP-1, and TSP-2 expression in rat granulation tissue. Journal of molecular medicine (Berlin, Germany). 2009 Academic Article GET IT
Times cited: 15
A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint. Apoptosis : an international journal on programmed cell death. 2009 Academic Article GET IT
Times cited: 33
Anti- and pro-tumor functions of autophagy. Biochimica et biophysica acta. 2009 Review GET IT
Times cited: 328
Necroptosis: a specialized pathway of programmed necrosis. Cell. 2008 Comment GET IT
Times cited: 439
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell death and differentiation. 2008 Academic Article GET IT
Times cited: 2264
Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell cycle (Georgetown, Tex.). 2008 Academic Article GET IT
Times cited: 231
Life, death and burial: multifaceted impact of autophagy. Biochemical Society transactions. 2008 Review GET IT
Times cited: 110
Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochimica et biophysica acta. 2008 Review GET IT
Times cited: 109
Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison. Biochemical pharmacology. 2008 Academic Article GET IT
Times cited: 28
Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells. Cell cycle (Georgetown, Tex.). 2008 Academic Article GET IT
Times cited: 28
Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. Cancer research. 2008 Academic Article GET IT
Times cited: 101
Mechanisms of p53-mediated mitochondrial membrane permeabilization. Cell research. 2008 Comment GET IT
Times cited: 30
Targeting p53 to mitochondria for cancer therapy. Cell cycle (Georgetown, Tex.). 2008 Review GET IT
Times cited: 96
Viral control of mitochondrial apoptosis. PLoS pathogens. 2008 Review GET IT
Times cited: 344
Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene. 2008 Comment GET IT
Times cited: 88
Regulation of autophagy by cytoplasmic p53. Nature cell biology. 2008 Academic Article GET IT
Times cited: 935
Senescence, apoptosis or autophagy? When a damaged cell must decide its path--a mini-review. Gerontology. 2008 Review GET IT
Times cited: 205
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene. 2008 Academic Article GET IT
Times cited: 184
To die or not to die: that is the autophagic question. Current molecular medicine. 2008 Review GET IT
Times cited: 227
No death without life: vital functions of apoptotic effectors. Cell death and differentiation. 2008 Review GET IT
Times cited: 217
Unexpected role of the phosphate carrier in mitochondrial fragmentation. Cell death and differentiation. 2008 Letter GET IT
Times cited: 11
Methods for assessing autophagy and autophagic cell death. Methods in molecular biology (Clifton, N.J.). 2008 Academic Article GET IT
Times cited: 167
Methods to dissect mitochondrial membrane permeabilization in the course of apoptosis. Methods in enzymology. 2008 Academic Article GET IT
Times cited: 29
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway. PloS one. 2007 Academic Article GET IT
Times cited: 69
Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Molecular cell. 2007 Academic Article GET IT
Times cited: 95
Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood. 2007 Academic Article GET IT
Times cited: 97
Apaf-1 Deficiency Causes Chromosomal Instability. Cell cycle (Georgetown, Tex.). 2007 Academic Article GET IT
Times cited: 25
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer research. 2007 Academic Article GET IT
Times cited: 121
Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis : an international journal on programmed cell death. 2007 Review GET IT
Times cited: 183
Mitochondrial apoptosis without VDAC. Nature cell biology. 2007 Comment GET IT
Times cited: 77
Cell death modalities: classification and pathophysiological implications. Cell death and differentiation. 2007 Review GET IT
Times cited: 632
Mitochondrial control of cell death induced by hyperosmotic stress. Apoptosis : an international journal on programmed cell death. 2007 Academic Article GET IT
Times cited: 81
Mitochondrial membrane permeabilization in cell death. Physiological reviews. 2007 Review GET IT
Times cited: 2908
Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene. 2006 Review GET IT
Times cited: 302
Whole cell strategies based on lux genes for high throughput applications toward new antimicrobials. Combinatorial chemistry & high throughput screening. 2006 Academic Article GET IT
Times cited: 35
Intracellular redox equilibrium and growth phase affect the performance of luciferase-based biosensors. Journal of biotechnology. 2006 Academic Article GET IT
Times cited: 27
Mechanisms of cytochrome c release from mitochondria. Cell death and differentiation. 2006 Review GET IT
Times cited: 917
Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy. Antiviral therapy. 2005 Academic Article GET IT
Times cited: 25
Changes in mitochondrial RNA production in cells treated with nucleoside analogues. Antiviral therapy. 2005 Academic Article GET IT
Times cited: 43
Discarding multidrug resistance inducers, the possible role of a biosensing reporter in antimicrobial discovery. Luminescence : the journal of biological and chemical luminescence. 2004 Academic Article GET IT
Times cited: 3
Amplified detection of transcriptional and translational inhibitors in bioluminescent Escherichia coli K-12. Journal of biomolecular screening. 2003 Academic Article GET IT
Times cited: 10
A real-time analysis of QacR-regulated multidrug resistance in Staphylococcus aureus. Biochemical and biophysical research communications. 2003 Academic Article GET IT
Times cited: 12

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Extending the survival of HR+ breast cancer patients receiving CDK4/6 inhibitors by targeting IL17-producing gamma delta T cells awarded by United States Department of Defense Principal Investigator 2022 - 2025
The influence of homologous recombination deficiency on tumor immunity and immunotherapy efficacy. awarded by Starr Cancer Consortium Principal Investigator 2023 - 2024
Evaluate the OX425 dosing schedules awarded by Onxeo SA Principal Investigator 2023 - 2024
Characterization of the interaction between LTX compounds and immunotherapy in breast cancer awarded by Lytix Biopharma AS - for Migration Principal Investigator 2022 - 2023
OX413 and OX425 Material from ONXEO awarded by Onxeo SA Principal Investigator 2022 - 2023

Biochemical and functional characterization of a novel anti-inflammatory biogenic amine awarded by National Institute of Allergy & Infectious Diseases Co-Investigator 2023 - 2028
Dynamics of Immune Response in Irradiated Rectal Cancer awarded by National Cancer Institute Co-Investigator 2022 - 2027
Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory awarded by United States Department of Defense Co-Investigator 2021 - 2025
Converting HR+ Breast Cancer Into an Individualized Vaccine awarded by United States Department of Defense Co-Investigator 2019 - 2023
DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME awarded by National Institute of Allergy & Infectious Diseases Co-Investigator 2019 - 2023
Longitudinal functional genomics in mantle cell lymphoma therapy and drug resistance awarded by Leukemia & Lymphoma Society, Inc. Co-Investigator 2018 - 2023

Breaking resistance of breast cancer to radiotherapy-CDK4/6 inhibitors combination by targeting cancer stem cells awarded by American Italian Cancer Foundation Key Personnel 2022 - 2023

more ...

less ...

Background

education and training

Ph.D., Universite Paris SUD XI (France) 2008
M.Sc., University of Modena and Reggio Emilia (ITaly) 2004

Contact

full name

Lorenzo Galluzzi

primary email

log3001@med.cornell.edu

VIVO Weill Cornell Medical College

Lorenzo Galluzzi Assistant Professor of Cell Biology in Radiation Oncology

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email